SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001513162-18-000133
Filing Date
2018-05-15
Accepted
2018-05-15 17:18:13
Documents
78
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q form10q.htm 10-Q 1450885
2 EXHIBIT 31.1 exhibit31_1.htm EX-31.1 10959
3 EXHIBIT 31.2 exhibit31_2.htm EX-31.2 10914
4 EXHIBIT 32.1 exhibit32_1.htm EX-32.1 7755
5 EXHIBIT 32.2 exhibit32_2.htm EX-32.2 7646
  Complete submission text file 0001513162-18-000133.txt   6657774

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT vxrt-20180331.xml EX-101.INS 1478614
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vxrt-20180331.xsd EX-101.SCH 66745
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vxrt-20180331_cal.xml EX-101.CAL 51729
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vxrt-20180331_def.xml EX-101.DEF 320364
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT vxrt-20180331_lab.xml EX-101.LAB 423633
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vxrt-20180331_pre.xml EX-101.PRE 320474
Mailing Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35285 | Film No.: 18837814
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1